Exploring Phytochemicals for Inhibitory Potential against Key Rheumatoid Arthritis Receptors and Cytokines: An <i>In Silico</i> Approach

Background: Rheumatoid Arthritis (RA) is an autoimmune disease which not only affects the synovial joints but also leads to other co-morbidities. Existing treatments provide only symptomatic relief to patients. This highlights the need for safer and more effective natural lead compounds. Aim: To identify potential natural lead compounds for RA by virtually screening selected phytoconstituents against key inflammatory and immunological targets. Methods: In urge to search a natural lead candidate, a virtual screening was performed with a total of 27 phytoconstituents against cyclooxygenase-1 (COX-1), cyclooxygenase-2 (COX-2), interleukin-6 (IL-6), Janus kinase-1 (JAK-1), Janus kinase-2 (JAK-2), mitogen-activated protein kinase-14 (MAPK-14), matrix metalloproteinase-9 (MMP9), and tissue necrosis factor-? (TNF-?) using PyRx software. Their ADME prediction was performed using SwissADME. Further, Molinspiration was used to determine the bioactivity score of the selected phytoconstituents as G-Protein Coupled Receptors (GPCR) ligand, Kinase Inhibitor (KI), Ion Channel Modulator (ICM), Protease Inhibitor (PI), Nuclear Receptor Ligand (NRL), and Enzyme Inhibitor (EI). The toxicity of these phytoconstituents was also predicted with the Protox-II web server. Results: The docking results displayed that hesperidin, sanguinarine, hecogenin, berberine, naringenin, genistein, piperine, and epicatechin-3-gallate have better binding affinity than the standard drug methotrexate with all the studied receptors. Most of the molecules showed acceptable druglikeness and leadlikeness properties and followed Lipinski�s rule of five. All these molecules were found to have moderate activity as GPCR ligands, KI, ICM, PI, NRL, and EI. Further, the toxicity prediction gave promising results. Conclusion: The results revealed that these bioactive compounds can provide novel lead candidates that might modulate immunological factors, which in turn prevent rheumatoid arthritis. Major Findings: The vi

View article page

Download PDF